Profile data is unavailable for this security.
About the company
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
- Revenue in USD (TTM)78.68m
- Net income in USD-64.25m
- Incorporated1996
- Employees212.00
- LocationSimulations Plus Inc800 Park Offices Drive, Suite 401RESEARCH TRIANGLE PARK 27709United StatesUSA
- Phone+1 (661) 723-7723
- Fax+1 (661) 723-5524
- Websitehttps://www.simulations-plus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Electromed Inc | 68.86m | 8.99m | 199.44m | 177.00 | 23.46 | 4.39 | 19.57 | 2.90 | 1.03 | 1.03 | 7.86 | 5.49 | 1.28 | 4.59 | 2.69 | 389,045.20 | 16.78 | 9.33 | 20.17 | 11.04 | 78.23 | 76.56 | 13.06 | 8.40 | 4.49 | -- | 0.00 | 0.00 | 16.97 | 14.53 | 46.35 | 12.62 | -20.72 | -- |
| SANUWAVE Health Inc | 41.28m | -7.04m | 206.34m | 46.00 | -- | -- | -- | 5.00 | -0.9346 | -0.9346 | 4.68 | -0.3418 | 1.44 | 1.75 | 11.07 | 897,456.50 | -24.53 | -124.81 | -- | -- | 78.26 | 71.67 | -17.06 | -144.71 | 0.808 | 0.0999 | 1.14 | -- | 59.99 | 99.65 | -21.56 | -- | 55.47 | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 206.51m | 288.00 | 15.20 | 1.41 | 10.21 | 2.51 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| Stereotaxis Inc | 30.07m | -24.91m | 207.18m | 139.00 | -- | 32.27 | -- | 6.89 | -0.281 | -0.281 | 0.3393 | 0.1266 | 0.6232 | 1.47 | 4.54 | 216,359.70 | -48.96 | -31.30 | -85.25 | -43.31 | 53.07 | 62.81 | -78.56 | -56.04 | 0.8108 | -- | 0.00 | -- | 0.5491 | -1.41 | -14.95 | -- | 2.89 | -- |
| OraSure Technologies Inc | 125.70m | -60.24m | 212.33m | 501.00 | -- | 0.5909 | -- | 1.69 | -0.8107 | -0.8107 | 1.69 | 5.01 | 0.2834 | 2.07 | 4.91 | 250,904.20 | -13.08 | -0.8506 | -14.16 | -0.9596 | 40.41 | 44.80 | -46.15 | -1.39 | 6.20 | -- | 0.0005 | -- | -54.17 | 3.75 | -136.34 | -- | -16.43 | -- |
| Utah Medical Products Inc | 38.63m | 11.62m | 213.76m | 155.00 | 18.98 | 1.82 | 14.69 | 5.53 | 3.54 | 3.54 | 11.75 | 36.91 | 0.307 | 1.92 | 10.38 | 249,245.20 | 9.24 | 12.08 | 9.48 | 12.53 | 57.10 | 60.88 | 30.08 | 31.04 | 29.36 | -- | 0.00 | 37.43 | -18.56 | -2.70 | -16.60 | -0.8254 | -59.49 | 1.83 |
| CVRx Inc | 56.65m | -53.31m | 216.28m | 223.00 | -- | 5.50 | -- | 3.82 | -2.04 | -2.04 | 2.17 | 1.49 | 0.4756 | 0.6837 | 5.68 | 254,040.40 | -44.76 | -39.12 | -49.79 | -42.10 | 85.33 | 82.74 | -94.10 | -130.77 | 6.72 | -8.80 | 0.5574 | -- | 10.45 | 56.40 | 11.10 | -- | 13.27 | -- |
| KORU Medical Systems Inc | 39.07m | -3.71m | 225.59m | 80.00 | -- | 13.69 | -- | 5.77 | -0.0807 | -0.0807 | 0.8482 | 0.3557 | 1.43 | 3.53 | 7.39 | 488,383.00 | -13.62 | -19.85 | -18.41 | -23.16 | 62.32 | 59.62 | -9.50 | -24.86 | 1.92 | -- | 0.0335 | -- | 17.98 | 7.75 | 55.85 | -- | 25.82 | -- |
| 908 Devices Inc | 57.64m | -57.10m | 239.24m | 246.00 | -- | 1.75 | -- | 4.15 | -1.61 | -0.1116 | 1.62 | 3.77 | 0.3123 | 1.76 | 4.17 | 234,296.80 | -30.94 | -18.01 | -37.82 | -19.67 | 49.35 | 52.89 | -99.07 | -78.45 | 3.12 | -- | 0.00 | -- | 18.72 | 27.11 | -98.37 | -- | 8.96 | -- |
| Simulations Plus Inc | 78.68m | -64.25m | 244.38m | 212.00 | -- | 1.92 | -- | 3.11 | -3.20 | -3.20 | 3.90 | 6.31 | 0.4701 | -- | 4.28 | 371,113.20 | -38.39 | -2.50 | -40.84 | -2.65 | 59.60 | 69.96 | -81.66 | -7.29 | -- | -- | 0.00 | -- | 13.09 | 13.74 | -750.17 | -- | 7.57 | -24.21 |
| Applied Energetics Inc | 1.15m | -13.02m | 244.68m | 21.00 | -- | -- | -- | 212.19 | -0.0599 | -0.0599 | 0.0053 | -0.0033 | 0.3065 | -- | 7.70 | 54,908.57 | -345.27 | -139.08 | -454.84 | -208.36 | 58.58 | 60.61 | -1,126.59 | -473.16 | -- | -- | -- | -- | -7.78 | -- | -24.71 | -- | 51.42 | -- |
| Orchestra Biomed Holdings Inc | 2.82m | -75.10m | 247.32m | 70.00 | -- | 5.65 | -- | 87.76 | -1.82 | -1.82 | 0.0676 | 0.7746 | 0.0313 | 0.6578 | 33.75 | 40,257.14 | -83.39 | -- | -104.85 | -- | 93.01 | -- | -2,665.05 | -- | 4.72 | -- | 0.2451 | -- | -4.42 | -- | -24.23 | -- | -- | -- |
| Cibus Inc | 3.79m | -118.90m | 251.91m | 157.00 | -- | 3.87 | -- | 66.40 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| CapsoVision Inc | 13.09m | -22.56m | 252.49m | -- | -- | 12.34 | -- | 19.29 | -0.4873 | -0.4873 | 0.2826 | 0.4368 | -- | -- | -- | -- | -- | -- | -- | -- | 53.13 | -- | -172.37 | -- | 4.50 | -- | 0.00 | -- | 20.54 | -- | -76.01 | -- | -- | -- |
| Shoulder Innovations Inc | 41.63m | -34.45m | 278.74m | 61.00 | -- | 1.88 | -- | 6.70 | -1.91 | -1.91 | 2.24 | 7.18 | -- | -- | -- | -- | -- | -- | -- | -- | 76.67 | -- | -82.75 | -- | 9.80 | -- | 0.0913 | -- | 64.07 | -- | -50.85 | -- | -- | -- |
| Trubridge Inc | 349.88m | 5.42m | 286.22m | 3.20k | 51.41 | 1.59 | 8.93 | 0.8181 | 0.3709 | 0.3709 | 24.23 | 12.02 | 0.8737 | 257.08 | 6.17 | 109,338.40 | 1.39 | -0.9107 | 1.60 | -1.03 | 53.16 | 50.13 | 1.59 | -1.14 | 1.90 | 2.40 | 0.4768 | -- | 0.946 | 4.52 | 56.05 | -- | 61.10 | -- |
Data as of Mar 03 2026. Currency figures normalised to Simulations Plus Inc's reporting currency: US Dollar USD
40.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Light Asset Management LLCas of 31 Jan 2026 | 2.65m | 13.17% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 1.09m | 5.41% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 890.41k | 4.42% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 595.20k | 2.96% |
| Marshall Wace LLPas of 31 Dec 2025 | 569.78k | 2.83% |
| Stephens Investment Management Group LLCas of 31 Dec 2025 | 525.53k | 2.61% |
| Tributary Capital Management LLCas of 31 Dec 2025 | 520.86k | 2.59% |
| First Eagle Investment Management LLCas of 31 Dec 2025 | 457.16k | 2.27% |
| Rockefeller & Co. LLCas of 31 Dec 2025 | 404.91k | 2.01% |
| Royce & Associates LPas of 31 Dec 2025 | 402.42k | 2.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
